Emicizumab in children: bleeding episodes and outcome before and after transition to emicizumab

HIGHLIGHTS

• who: Hannah Glonnegger from the Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany have published the research: Emicizumab in children: bleeding episodes and outcome before and after transition to Emicizumab, in the Journal: (JOURNAL)
• what: The authors show that minor surgery in patients receiving Emicizumab prophylaxis is safe and that no bleeding or thrombosis occurred, even if few doses of rFVlla were
• future: Although this current study provides crucial information about treatment of PUPs future studies e_g the Haemophilia . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.